Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 5/20 | 0.55 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.54 |
| ▸ | CXCL8 | P10145 | 6/20 | 0.54 |
| ▸ | CCKBR | P32239 | 2/20 | 0.50 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.50 |
| ▸ | GLP1R | P43220 | 2/20 | 0.50 |
| ▸ | NPY1R | P25929 | 1/20 | 0.50 |
| ▸ | NPY2R | P49146 | 1/20 | 0.50 |
| ▸ | NPY4R | P50391 | 1/20 | 0.50 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.50 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31606483 | 0.93 | CXCL8 (0.56) | KISS1RCXCL8CCKBRGLP1R | |
| SCHEMBL31606498 | 0.92 | CXCL8 (0.54) | KISS1RCXCL8CCKBRGLP1R | |
| SCHEMBL31606516 | 0.90 | CXCL8 (0.50) | KISS1RCXCL8CCKBR | |
| SCHEMBL31606507 | 0.88 | CASP1 (0.54) | KISS1RCXCL8CCKBRGLP1R | |
| SCHEMBL31606526 | 0.88 | AGTR1 (0.50) | KISS1RCCKBRGLP1R | |
| SCHEMBL31606491 | 0.88 | C5AR1 (0.61) | KISS1REPHA2GLP1RNPY1RNPY2R | |
| SCHEMBL31606497 | 0.87 | CASP1 (0.53) | KISS1RCXCL8CCKBRGLP1R | |
| SCHEMBL31606517 | 0.86 | KISS1R (0.58) | KISS1RCXCL8CCKBRIL23RGLP1R | |
| SCHEMBL31606530 | 0.86 | CXCL8 (0.57) | KISS1RCXCL8CCKBR | |
| SCHEMBL31606508 | 0.85 | CXCL8 (0.58) | KISS1RCXCL8CCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025109003-A1 | P-CADHERIN LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-05-30 | — | — | WO | disclosed |